Matthew D. Park, Ph.D.
@MatthewD_Park
Followers
572
Following
879
Statuses
465
M.D./Ph.D. candidate @SinaiMSTP in @MiriamMerad lab | Icahn School of Medicine at Mount Sinai
Joined May 2019
Thrilled to share our first study on aging from @MiriamMerad lab @IcahnMountSinai @TischCancer @SinaiImmunol in which we demonstrate how aging promotes cancer. We show that: (1/n)
25
69
292
I'm excited to share a new review @NatureRevCancer from @MiriamMerad lab @SinaiImmunol led by X-less Chang Moon. We offer one of the most comprehensive reviews of DC functions, phenotypes, and maturation at steady-state and in cancer. It is a must-read!
2
23
139
(6/n) This axis can be therapeutically targeted to enhance immunity (lung cancer), which highlights major clinical implications for the use of AXL inhibitors to treat cancer as more than just a direct tumor cell target. It is a vital DC immunotherapy agent!
0
0
0
RT @LabWaggoner: Cholesterol mobilization regulates DC maturation and the immunogenic response to cancer @NatImmuno…
0
11
0
RT @GradSchoolSinai: Matthew Park, PhD is a sixth-year candidate in the MD-PhD program at @IcahnMountSinai. He was recognized in the 2025 @…
0
1
0
RT @IcahnMountSinai: Congratulations to @MatthewD_Park, MD/PhD Candidate, on being recognized in @ForbesUnder30 Healthcare list! @Forbes #…
0
2
0
@clec9Andrew @Forbes @ForbesUnder30 @MiriamMerad @SinaiImmunol @IcahnMountSinai @TischCancer Thanks Andrew!
0
0
0
RT @SinaiImmunol: We're THRILLED to congratulate @MatthewD_Park on being named one of @Forbes 30 under 30 in Healthcare 🥳!!! Check out his…
0
4
0
RT @TischCancer: .@MatthewD_Park on the 2025 30 Under 30 - Healthcare - Park's doctoral research, published in Science, has advanced our un…
0
2
0
RT @NCICancerBio: #SITC24: @MeriemBelabed @IcahnMountSinai is presenting a poster showing that AXL restricts cholesterol mobilization, whic…
0
4
0
Very excited to be presenting work from @MiriamMerad lab @IcahnMountSinai @SinaiImmunol on mechanisms of pathogenic myelopoiesis in cancer and aging @sitcancer and to be receiving a Young Investigator Award #SITC2024 ! Join us tomorrow in Session 208a 5:15 pm CST.
0
1
42
RT @TischCancer: Ovarian cancer-derived IL-4 promotes immunotherapy resistance: Cell @IcahnInstitute @IcahnMountSi…
0
9
0
RT @EricTopol: Spatial omics of ovarian cancer shows how the tumor blocks the patient's immune response and immunotherapy via interleukin-…
0
75
0